Your browser doesn't support javascript.
loading
Neurotransmitters: Impressive regulators of tumor progression.
Yang, Yumei; Sun, Lei; Liu, Xuerou; Liu, Wei; Zhang, Zhen; Zhou, Xingqi; Zhao, Xinli; Zheng, Ruijie; Zhang, Yongjun; Guo, Wanqing; Wang, Xiaoli; Li, Xian; Pang, Jinlong; Li, Feng; Tao, Yu; Shi, Dongmin; Shen, Wenyi; Wang, Liping; Zang, Jialan; Li, Shanshan.
Afiliação
  • Yang Y; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Sun L; Department of Critical Care Medicine, The First Hospital of Harbin, No 151, Diduan Street, Daoli District, Harbin, China.
  • Liu X; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Liu W; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Zhang Z; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Zhou X; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Zhao X; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Zheng R; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Zhang Y; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Guo W; School of Pharmacy, Bengbu Medical University, Bengbu, China.
  • Wang X; College of Pharmacy, Anhui University of Traditional Chinese Medicine, China.
  • Li X; School of Pharmacy, Bengbu Medical University, Bengbu, China; Anhui Province Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, China.
  • Pang J; School of Pharmacy, Bengbu Medical University, Bengbu, China; Anhui Province Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, China.
  • Li F; School of Pharmacy, Bengbu Medical University, Bengbu, China; Anhui Province Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, China.
  • Tao Y; School of Pharmacy, Bengbu Medical University, Bengbu, China; Anhui Province Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, China.
  • Shi D; Department of Day Surgery Ward, The First Hospital of Harbin, No 151, Diduan Street, Daoli District, Harbin, China.
  • Shen W; Department of Respiratory and Critical Care Medicine, Lianshui County People's Hospital, Jiangsu, China.
  • Wang L; Department of Day Surgery Ward, The First Hospital of Harbin, No 151, Diduan Street, Daoli District, Harbin, China.
  • Zang J; Department of Day Surgery Ward, The First Hospital of Harbin, No 151, Diduan Street, Daoli District, Harbin, China. Electronic address: 17856995721@163.com.
  • Li S; School of Pharmacy, Bengbu Medical University, Bengbu, China; Anhui Province Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu, China. Electronic address: Lishanshan900122@163.com.
Biomed Pharmacother ; 176: 116844, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38823279
ABSTRACT
In contemporary times, tumors have emerged as the primary cause of mortality in the global population. Ongoing research has shed light on the significance of neurotransmitters in the regulation of tumors. It has been established that neurotransmitters play a pivotal role in tumor cell angiogenesis by triggering the transformation of stromal cells into tumor cells, modulating receptors on tumor stem cells, and even inducing immunosuppression. These actions ultimately foster the proliferation and metastasis of tumor cells. Several major neurotransmitters have been found to exert modulatory effects on tumor cells, including the ability to restrict emergency hematopoiesis and bind to receptors on the postsynaptic membrane, thereby inhibiting malignant progression. The abnormal secretion of neurotransmitters is closely associated with tumor progression, suggesting that focusing on neurotransmitters may yield unexpected breakthroughs in tumor therapy. This article presents an analysis and outlook on the potential of targeting neurotransmitters in tumor therapy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurotransmissores / Progressão da Doença / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurotransmissores / Progressão da Doença / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article